Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
Detection of residual tumours in postchemotherapy testicular cancer by FDG-PETJ M Nuutinen, S Leskinen, I Elomaa, et al.
Journal of Neurology|September 19, 2000
Risk for Parkinson's disease: twin studies for the detection of asymptomatic subjects using [18F]6-fluorodopa PETA Laihinen, H Ruottinen, J O Rinne, et al.
The American Journal of Psychiatry|February 15, 2000
Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomographyA Laakso, H Vilkman, B Alakare, et al.
Lancet (London, England)|October 28, 1995
Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patientsJ Hietala, E Syvälahti, K Vuorio, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2001
Imaging of blood flow and hypoxia in head and neck cancer: initial evaluation with [(15)O]H(2)O and [(18)F]fluoroerythronitroimidazole PETK Lehtiö, V Oikonen, T Grönroos, et al.
Synapse (New York, N.Y.)|February 15, 2001
Detection of response to COMT inhibition in FDOPA PET in advanced Parkinson's disease requires prolonged imagingH M Ruottinen, M Niinivirta, J Bergman, et al.
Diabetes|January 1, 1995
Gender and insulin sensitivity in the heart and in skeletal muscles. Studies using positron emission tomographyP Nuutila, M J Knuuti, M Mäki, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1995
FDG-PET in early infancy: simplified quantification methods to measure cerebral glucose utilizationH Suhonen-Polvi, U Ruotsalainen, A Kinnala, et al.
Acta Neurologica Scandinavica|January 1, 1990
Striatal kinetics of [11C]-(+)-nomifensine and 6-[18F]fluoro-L-dopa in Parkinson's disease measured with positron emission tomographyJ Tedroff, S M Aquilonius, A Laihinen, et al.
Nuclear Medicine Communications|October 1, 1984
Imaging of canine cancers with 18F-2-fluoro-2-deoxy-D-glucose (FDG) suggests further applications for cancer imaging in manR Paul, R Johansson, A Kiuru, et al.
Pageof 8